With very large sample sizes, population-based cohorts and biobanks provide an exciting opportunity to identify genetic components of complex traits. To analyze rare variants, gene or region-based multiple variant aggregate tests are commonly used to increase association test power. However, due to the substantial computation cost, existing region-based rare variant tests cannot analyze hundreds of thousands of samples while accounting for confounders, such as population stratification and sample relatedness. Here we propose a scalable generalized mixed model region-based association test that can handle large sample sizes. This method, SAIGE-GENE, utilizes state-of-the-art optimization strategies to reduce computational and memory cost, and hence is applicable to exome-wide and genome-wide regionbased analysis for hundreds of thousands of samples. Through the analysis of the HUNT study of 69,716 Norwegian samples and the UK Biobank data of 408,910 White British samples, we show that SAIGE-GENE can efficiently analyze large sample data (N > 400,000) with type I error rates well controlled.
Introduction
In recent years, large cohort studies and biobanks, such as Trans-Omics for Precision Medicine (TOPMed) study and UK Biobank 1 , have sequenced or genotyped hundreds of thousands of samples, which are invaluable resources to identify genetic components of complex traits, including rare variants (minor allele frequency (MAF) < 1%). It is well known that single variant tests are underpowered to identify traitassociated rare variants 2 . Gene-or region-based tests, such as Burden test, SKAT 3 and SKAT-O 4 , can be more powerful by grouping rare variants into functional units, i.e. genes. To adjust for both population structure and sample relatedness, gene-based tests have been extended to mixed models 5,6 . For example, EmmaX 5 based SKAT 3 approaches (EmmaX-SKAT) have been implemented and used for many rare variant association studies including TOPMed 7 . The generalized linear mixed model gene-based test, SMMAT, has been recently developed 6 . However, these approaches require O( " ) computation time and O( # ) memory usages, where is the sample size, which are not scalable to large datasets.
Here, we propose a novel method called SAIGE-GENE for region-based association analysis that is capable of handling very large samples (> 400,000 individuals), while inferring and accounting for sample relatedness. SAIGE-GENE is an extension of the previously developed single variant association method, SAIGE 8 , with a modification suitable to rare variants. Same as SAIGE, it utilizes state-of-the-art optimization strategies to reduce computation cost for fitting null mixed models. To ensure the computation efficiency while improving test accuracy for rare variants, SAIGE-GENE approximates the variance of score statistics calculated with the full genetic relationship matrix (GRM) using the variance calculated with a sparse GRM and the ratios of these two variances estimated from a subset of genetic markers. Because the sparse GRM, constructed by thresholding small values in the full GRM, preserves close family structures, this approach provides a far more accurate variance estimation for very rare variants (minor allele count (MAC) < 20) than the original approach in SAIGE. By combining single variant score statistics, SAIGE-GENE can perform Burden, SKAT and SKAT-O type gene-based tests. We have also developed conditional analysis, which performs association tests with conditioning on a single variant or multiple variants to identify independent rare variant association signals.
We have demonstrated that SAIGE-GENE controls for type I error rates in related samples through extensive simulations as well as the real data analysis, including the HUNT study for 69,716 Norwegian samples 9,10 and the UK Biobank for 408,910 White British samples 1 . By evaluating its computation performance, we have shown the feasibility of SAIGE-GENE for large-scale genome-wide analysis. To perform exome-wide gene-based tests on 400,000 samples with on average 50 markers per gene, SAIGE-GENE requires 2,238 CPU hours and less than 36 Gb memory, while current methods will cost more than > 10 Tb in memory. We have further applied SAIGE-GENE to 53 quantitative traits in the UK Biobank and identified several significantly associated genes through exome-wide gene-based tests.
RESULTS

Overview of Methods
SAIGE-GENE consists of two main steps: 1. Fitting the null generalized linear mixed model (GLMM) to estimate variance components and other model parameters. 2. Testing for association between each genetic variant set, such as a gene or a region, and the phenotype. Three different association tests: Burden, SKAT, and SKAT-O have been implemented in SAIGE-GENE. The workflow is shown in the Supplementary Figure 1 .
SAIGE-GENE uses similar optimization strategies as utilized in the original SAIGE to achieve the scalability for fitting the null GLMM and estimating the model parameters in Step 1. In particular, the spectral decomposition has been replaced by the preconditioning conjugate gradient (PCG) to solve linear systems without calculating and inverting the × GRM. To reduce the memory usage, raw genotypes are stored in a binary vector and elements of GRM are calculated when needed rather than being stored.
One of the most time-consuming part in association tests is to calculate variance of single variant score statistic, which requires O( # ) computation. In SAIGE 8 , BOLT-LMM 11 , and GRAMMA-Gamma 12 , in order to reduce the computation cost, the variance with GRM is approximated using the variance without GRM and the estimated ratio of the two variances. The ratio, which is assumed to be constant, is estimated using a subset of randomly selected genetic markers. However, for very rare variants with MAC below 20, the constant ratio assumption is not satisfied (Supplementary Figure 2, left panel) . This is because rare variants are more susceptible to close family structures. Thus, to better approximate the variance, SAIGE-GENE incorporates close family structures through a sparse GRM, in which GRM elements below a userspecified relatedness coefficient are zeroed out and close family structures are preserved. The ratio between the variance with the full GRM and with the sparse GRM is much less variable ( Supplementary  Figure 2, right panel) . To construct a sparse GRM, a small subset of randomly selected genetic markers, i.e. 2,000, are firstly used to quickly estimate which sample pairs pass the user-specified coefficient of relatedness cutoff, e.g. ≥0.125 for up to 3 rd degree relatives. Then the coefficients of relatedness for those related pairs are further estimated using the full set of genetic markers, which equal to values in the full GRM. Once the sparse GRM has been computed for a biobank or a data set, it can be re-used for downstream genetic association tests for any phenotype. Heritability estimates using a sparse GRM with up to 3 rd degree relatives preserved for 24 quantitative traits with sample size ≥ 100,000 in the UK Biobank are close to the estimates using the full GRM (Supplementary Figure 3) . Moreover, given that estimated values for variance ratios may vary by MAC for the extremely rare variants ( Supplementary  Figure 2, left panel) , such as singletons and doubletons, the variance ratio can be estimated by different MAC categories. By default, MAC categories are set to be MAC equals to 1, 2, 3, 4, 5, 6 to 10, 11 to 20, and > 20. In Step 2, gene-based tests are conducted using single variant score statistics and their covariance estimates, which are approximated as the product of the covariance with the sparse GRM and the preestimated ratio. SAIGE-GENE can carry out Burden, SKAT, and SKAT-O approaches. Since SKAT-O is a combined test of Burden and SKAT, and hence provides a robust power, SAIGE-GENE performs SKAT-O by default.
If a gene or a region is significantly associated with the phenotype of interest, it is necessary to test if the signal is from rare variants or just a shadow of common variants in the same locus. We have developed the conditional analysis using linkage disequilibrium (LD) information between conditioning markers and the tested gene 13 . Details of the conditional analysis are described in the Online Methods section. SAIGE-GENE uses the same generalized linear mixed model as in SMMAT, while SMMAT calculates the variances of the score statistics using the full GRM and hence can be thought of as the "exact" method. When the trait is continuous, the GLMM used by SAIGE-GENE and SMMAT is equivalent to the linear mixed mode (LMM) of EmmaX-SKAT. We have further shown that SAIGE-GENE provides consistent association p-values to the "exact" methods EmmaX-SKAT and SMMAT (r 2 of -log10 P-values > 0.99) using both simulation studies (Supplementary Figure 4) and real data analysis for down-sampled UK Biobank and HUNT (Supplementary Figure 5) , but with much smaller computation and memory cost (Figure 1 ).
Computation and Memory Cost
To evaluate the computation performance of SAIGE-GENE, we randomly sampled subsets of the 408,144 UK Biobank participants with the White British ancestry and non-missing measurements for waist hip ratio 1 . We benchmarked SAIGE-GENE, EmmaX-SKAT, and SMMAT for exome-wide gene-based SKAT-O tests, in which 15,342 genes were tested with assuming that each has 50 rare variants. log10 of memory usage is plotted against sample sizes in Figure 1A . The memory cost of SAIGE-GENE is linear to the number of markers, M1, used for kinship estimation, but too few markers may not be sufficient to account for subtle sample relatedness in the data, leading to inflated type I error rates in genetic association tests 8, 14 . SAIGE-GENE uses 11.74 Gb with M1 = 93,511 and 35.59 Gb when M1 = 340,447 when the sample size N is 400,000, making it feasible for large sample data. In contrast, with N = 400,000 the memory usages in EmmaX-SKAT and SMMAT are projected to be nearly 10Tb, which makes them impossible to be used for large sample data. log10 of total computation time for exome-wide gene-based tests is potted against the sample size as shown in Figure 1B Supplementary Table 1 . The computation time for Step 1 in SAIGE-GENE is approximately O(M1N 1.5 ) and in SMMAT and EmmaX-SKAT is O(N 3 ), where M1 is the number of markers used for estimating the full GRM and N is the sample size. In Step 2, the association test for each gene costs O( ) in SAIGE-GENE, where is the number of markers in the gene and K is the number of non-zero elements in the sparse GRM. Compared to O( # ) in Step 2 of SMMAT and EmmaX-SKAT, SAIGE-GENE decreases the computation time dramatically. For example, in the UK Biobank (N =408,910) with the relatedness coefficient ≥ 0.125 (corresponding to preserving samples with 3 rd degree or closer relatives in the GRM), = 493,536, which is the same order of magnitude of N, and hence O( ) is greatly smaller than ( # ). As the computation time in Step 2 is approximately linear to , the number of markers in each variant set, the total computation time for exome-wide gene-based tests was projected by different and has been plotted in Supplementary Figure 7 . In addition, we plotted the projected computation time for genome-wide region-based tests against the sample size as shown in Supplementary Figure 8 , in which 286,000 chunks with 50 markers per chunk were assumed to be tested, corresponding to the 14.3 million markers in the HRC-imputed UKB data with MAF ≤ 1% and imputation info score ≥ 0.8. SAIGE-GENE successfully controls for type I error rates for gene-based tests while accounting for relatedness among samples. It uses several optimization strategies that are similar to those used in SAIGE to make fitting the null generalized linear mixed models feasible for large sample sizes. For example, instead of storing the genetic relationship matrix (GRM) in the memory, SAIGE-GENE stores genotypes that are used for constructing the matrix in a binary vector and computes the elements of the matrix as needed. Preconditioned conjugate gradient algorithm is also used to solve linear systems instead of the Cholesky decomposition method. However, some optimization approaches are specifically applied in the gene-based tests in regard of the rare variants. Because computing variance of score statistics for genetic variants is computationally expensive as it requires the inversion of the GRM, SAIGE, similar to BOLT-LMM 11 and GRAMMA-Gamma 12 , approximates the variance by estimating the ratio of the variance with and without the GRM using a subset of random genetic markers. As estimating the variances of score statistics for rare variants are more sensible to family structures, we use a sparse GRM to preserve close family structures in SAIGE-GENE rather than ignoring all sample relatedness for the variance ratio. In addition, the variance ratios are estimated for different minor allele count (MAC) categories, especially for those extremely rare variants with MAC lower than or equal to 20.
SAIGE-GENE has some limitations. First, similar to SAIGE and other mixed-model methods, the time for algorithm convergence to fit the generalize linear mixed models may vary among phenotypes and study samples given different heritability levels and sample relatedness. Second, SAIGE-GENE is not yet able to handle unbalanced case-control ratios of binary traits, which causes inflated type I error rates, especially for rare variants. Therefore, we recommend using SAIGE-GENE for quantitative traits and binary traits with relatively balanced case-control ratios. In SAIGE, the issue of imbalanced case-control ratios for binary traits are successfully addressed by approximating the distribution of score statistics using saddlepoint approximation (SPA) 22 . In future work, we plan to apply SPA to SAIGE-GENE to make the method extendable to analyze binary traits with imbalanced case-control ratios.
Overall, we have shown that SAIGE-GENE can account for sample relatedness while maintaining test power through extensive simulation studies. By applying SAIGE-GENE to the HUNT study 9 and the UK Biobank 1 followed by conditioning on most significant variants in the testing loci, we have demonstrated that SAIGE-GENE can identify potentially novel association signals that are independent of the common signals from the single-variant association tests. Currently, our method is the only available mixed effect model approach for gene-or region-based rare variant tests for large sample data. By providing a scalable solution to the current largest and future even larger datasets, our method will contribute to identifying trait-susceptibility rare variants and genetic architecture of complex traits. Figure 2 . Quantile-quantile plots of exome-wide gene-based association results for A. high-density lipoprotein (HDL) in the HUNT study (N = 69,214). SKAT-O approach in SAIGE-GENE was performed for 13,416 genes with stop-gain and missense variants with MAF ≤ 1%, of which 10,600 having at least two variants are plotted. B. automated read pulse rate in the UK Biobank (N = 385,365). SKAT-O approach in SAIGE-GENE was performed for 15,338 genes with stop-gain and missense variants with MAF ≤ 1%, of which 12,638 having at least two variants are plotting.
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